Literature DB >> 29172775

C/EBPβ Promotion of MMP3-Dependent Tumor Cell Invasion and Association with Metastasis in Colorectal Cancer.

Yuanyuan Ji1, Junkuo Li2, Pan Li3, Li Wang3, Haijun Yang2, Guozhong Jiang3.   

Abstract

AIMS: Tumor metastasis is a significant obstacle to curing colorectal cancer (CRC). C/EBPβ is thought to play an important role in CRC invasion and metastasis. In this study, we assessed whether C/EBPβ-mediated tumor invasion was dependent on MMP3, the expression of which is upregulated by C/EBPβ. We then determined whether C/EBPβ upregulation was associated with MMP3 levels and metastatic status in human CRC patients.
MATERIALS AND METHODS: A total of 102 patients were recruited for this study. mRNA and protein levels of C/EBPβ and MMP3 in CRC cell lines and patient specimens were determined by reverse transcription-polymerase chain reaction and western blot, respectively. Tumor cell invasion was analyzed using an in vitro Matrigel Invasion Assay. The correlation between C/EBPβ and MMP3 expression was determined by Pearson's correlation analysis.
RESULTS: Both mRNA and protein levels of MMP3 were upregulated by C/EBPβ overexpression and downregulated by C/EBPβ siRNA in HCT116 CRC cell cultures. C/EBPβ-enhanced tumor cell invasion was inhibited by MMP3 siRNA. In human CRC patients, C/EBPβ levels were correlated with MMP3 levels and metastatic status.
CONCLUSIONS: C/EBPβ upregulation promoted tumor cell invasion in an MMP3-dependent manner in vitro and was associated with metastatic status in CRC.

Entities:  

Keywords:  C/EBPβ; MMP3; colorectal cancer; metastasis

Mesh:

Substances:

Year:  2017        PMID: 29172775     DOI: 10.1089/gtmb.2017.0113

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

1.  A Seven-NF-κB-Related Gene Signature May Distinguish Patients with Ulcerative Colitis-Associated Colorectal Carcinoma.

Authors:  Chao-Yi Ge; Li-Yuan Wei; Yu Tian; Hua-Hong Wang
Journal:  Pharmgenomics Pers Med       Date:  2020-12-02

2.  Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer.

Authors:  Wei Zhang; Hui Liu; Junjie Jiang; Yunyun Yang; Wenjie Wang; Zhengyan Jia
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response.

Authors:  Ailec Ho-Plágaro; Cristina Rodríguez-Díaz; Concepción Santiago-Fernández; Carlos López-Gómez; Sara García-Serrano; Flores Martín-Reyes; Francisca Rodríguez-Pacheco; Alberto Rodríguez-Cañete; Guillermo Alcaín-Martínez; Luis Vázquez-Pedreño; Sergio Valdés; Lourdes Garrido-Sánchez; Eduardo García-Fuentes
Journal:  Biomedicines       Date:  2022-04-29

4.  A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.

Authors:  Ilknur Calik; Muhammet Calik; Gulistan Turken; Ibrahim Hanifi Ozercan
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

5.  TNIP1 Inhibits Proliferation And Promotes Apoptosis In Clear Cell Renal Carcinoma Through Targeting C/Ebpβ.

Authors:  Yong Yang; Jinhai Fan; Shenglu Han; Enyuan Li
Journal:  Onco Targets Ther       Date:  2019-11-18       Impact factor: 4.147

6.  P2X7 receptor as an independent prognostic indicator in gastric cancer.

Authors:  Ilknur Calik; Muhammet Calik; Burcu Sarikaya; Ibrahim Hanifi Ozercan; Ramazan Arslan; Gokhan Artas; Adile Ferda Dagli
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

7.  SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.

Authors:  Pinping Jiang; Ying Cao; Feng Gao; Wei Sun; Jinhui Liu; Ziyan Ma; Manxin Xie; Shilong Fu
Journal:  BMC Cancer       Date:  2021-06-11       Impact factor: 4.430

8.  CCAAT/Enhancer-Binding Protein β Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor.

Authors:  Tingting Li; Xuan Cai; Xiangning Wang; Xueyan Zhang; Hui Zhang; Biwei Xu; Shiwei Li; Jianyan Hu; Qiang Wu
Journal:  J Diabetes Res       Date:  2020-03-09       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.